EFI (Endoscopic Force-reflecting Instruments) is a leading medical technology and device company specializing in laparoscopic minimal invasive surgery (MIS). With a strong focus on Haptic-Feedback, EFI has developed a cutting-edge platform and gained extensive expertise over more than 10 years. This platform addresses the lack of feeling in surgery by utilizing a portfolio of patented technologies, applicable to a range of minimal invasive surgical instruments.

In addition to their current instruments, EFI is actively working on developing robotic applications, aiming to make their haptic-feedback technology available for robotic instruments as well. Their flagship instrument, the OptiGrip, uses state-of-the-art optical sensor technology to provide controlled tissue feeling, delivering information on tissue stiffness and arterial pulsations through force feedback. The OptiGrip has undergone extensive pre-clinical studies and is on track to complete its CE trajectory in 2023.

Another innovative instrument from EFI is the OptiTouch, developed based on user study outcomes. It focuses on optimal detection of arterial pulsations and offers tactile feedback at the tip of the index finger, enhancing tactile sensitivity. With battery-powered force measurement and a cable-less design, the OptiTouch can be easily sterilized using standard hospital procedures.

EFI holds a strong portfolio of patents and proprietary knowledge on force reflecting technology, ensuring their position as a leader in the field. Their intellectual property, product design, and technical knowledge are protected by European and American patents and patent applications. Experience the future of surgery with EFI, where their advanced instruments provide haptic feedback, improve tissue manipulation, and enhance overall surgical performance